Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026

KR&SNOX Date: November 05, 2026 To, To, National Stock Exchange of India BSE Limited Limited 25" Floor, Exchange Plaza, C-1 Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Fort, Bandra [E],Mumbai - 400051 Mumbai - 400 001 NSE Scrip Symbol: KRONOX BSE Scrip Code: 544187 Subject: Outcome of Board Meeting held on Thursday, November 05, 2026. Dear Sir/Madam, Pursuantto Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that, Board of Directors at their meeting held today i.e. on Thursday, November 05, 2026 have considered, approved and took on record the followings: 1. Statement of Standalone Unaudited Financial Results for the quarter and half year ended on September 30, 2026 along with Statement of Assets and Liabilities as at September 30, 2026 and the Cash Flow Statement for the quarter and half-year ended on September 30, 2026 2. Independent Auditors’ Limited Review Report on Financial Results. 3. The draft Postal Ballot Notice for seeking shareholders approval for the proposed Resolutions. The said Postal Ballot Notice will be submitted to the Stock Exchange and will be dispatched to shareholders in due course. The Meetingo f Board of Directors commenced at 12:15 p.m. and concluded at 2:00 p.m. Kindly take the aforesaid information on your record and oblige. Thanking you For KRONOX Lab Sciences Limited Compahy Secretary & Compliance Officer Membership No. A68272 KRONOX LAB SCIENCES LIMITED Corporate Office Address : Block No. 284, Village : Dabhasa, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440. Registered Office Address : Block No. 138, Village : Ekalbara, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440. Phone No. : +91 2662 299002 CIN : L24117GJ2008PLC055460 Email : info@kronoxlabsciences.com, Webside : www.kronoxlabsciences.com KR&NOX KRONOX LAB SCIENCES LIMITED Regd. Office: Block No. 353, Village: Ekalbara, Taluka: Padra, District: Vadodara 391440 Gujarat email: cs@kronoxlabsciences.com ; CIN: L24117GJ2008PLC055460 Statement of Unaudited Financial Results for the Quarter and Six Months ended September 30, 2026 (Rs in lakhs) Quarter ended Six Months ended Year ended ;; Particulars 30.09.2026 | 30.06.2026 | 30.09.2025 | 30.09.2026 | 30.09.2025 | 31.03.2026 Unaudited | Unaudited | Unaudited | Unaudited | Unaudited Audited 1 [INCOME FROM OPERATIONS Revenue from Operations 2,683.42 2,838.64 2,553.32 5,522.06 498197 | 1012200 Other Income 86.87 129.66 104.21 21653 191.53 519.40 I TOTAL INCOME 2,770.29 2,968.30 2,657.53 5,738.59 5173.50 | 10,641.40 2 [EXPENSES a. Cost of Materials Consumed 1,108.38 1,509.30 1,021.42 2,617.68 2,308.65 4,713.80 b. Changes in Inventories of Finished Goods, 112,01 (111.40) 114.97 0.61 (8.11) (56.20) Work in Progress and Stock-In-Trade c. Employee Benefit Expenses 190.60 193.30 184.01 383.90 36241 74030 d. Finance Costs 7.85 330 392 1115 3.92 11.40 e. Depreciation and Amortisation Expenses 49.45 45.20 46.84 94.65 86.90 204.80 f. Other Expenses 428.64 347.60 368.37 776.24 646.29 1,297.00 TOTAL EXPENSES 1,896.93 1,987.30 1,739.53 3,884.23 3,400.06 6,911.10 3 |Profit/loss from operations before Tax (1-2) 873.36 981.00 918.00 1,854.36 1,773.44 3,730.30 4 [Tax Expenses a. Current Tax 233.97 253.00 250.00 486,97 468.60 972.00 b. Deferred Tax (4.64)] (2:30) 0.37 (6.94) (2.05) (7.70) Total Tax Expenses 22933 250.70 250.37 480.03 466.55 964.30 5 |Profit after Tax for the Period (3-4) 644.03 730.30 667.63 1374.33 1,306.89 2,766.00 6 |Other Comprehensive Income Item that will not be reclassified to profit or loss ~ o i. Defined benefit Plan liability/assets 059 (4.00) 7.94 (3.41) 11.19 29.00 ii. Tax Impact on above item (0.14) 100 (2.00) 0586 (2.82) (7.30) 0.45 (3.00) 5.94 (2.55) 8.37 21.70 7 [Total Comprehensive Income for the Period (5+6) 644.48 727.30 673.57 1371.78 1,315.26 2,787.70 8 |Paid-up Equity Share Capital (FV Rs.10/- per share) 3,710.40 3,710.40 3,710.40 3,710.40 3,710.40 3,710.40 9 |Reserves excluding Revaluation reserve 7,902.29 10 |Earning Per Equity Share (in Rs) Basic and Diluted 173 197 180 370 352 7.45 [Notes: 1 The above results have been reviewed and recommended by the Audit Committee and taken on record by the Board of Directors at their respective, Meeting held on November05 , 2026 2 The Company is having only one segment of activity namely 'Manufacturing and Selling of of High Purity Speciality Fine Chemical' the disclosure| requirement of the Indian Accounting Standard (AS) 108 "Operating Segments" notified under Section 133 of the Companies Act, 2013 read with rule 7] of the Companies (Accounts) Rule, 2014 are not applicable. 3 The Statutory Auditors have carried out a Limited Review of the unaudited Financial Results and have expressed an unmodified review report. KRONOX LAB SCIENCES LIMITED Corporate Office Address : Block No. 284, Village : Dabhasa, Taluka : Padra, Dist.: Vadodara, Gujarat State - 391 440." Registered Office Address : Block No. 353, Village : Ekalbara, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440. Phone No. : +91 02662 299002 CIN : L24117GJ2008PLC055460 Email : info@kronoxlabsciences.com, Webside : www.kronoxlabsciences.com KR&NOX 4 Pursuantto Share Purchase Agreement executed between the erstwhile Promoters of the Company and Indo Borax & Chemicals Limited on August 20, 2026, the Equity Shares of the Company representing 64.26% of the Paid-up Equity Shares Capital were transferred to Indo Borax & Chemicals Limited| on September 29, 2026. Consequently, Indo Borax Chemicals Limited became the Holding Company. Pursuant to change in controlling stake in the| Company, there is a change in the Board of Directors and Key Managerial Personnel of the Company effective from September 29, 2026. 5 Previous period figures have been regrouped/reclassified , wherever necessary, to make them comparable with the figures for the current period. For and on behalf of the Board of Directors Ir. Suresh Kalra Place: Mumbai Managing Director & CEQ Date : November05 , 2026 DIN: 02833715 KRONOX LAB SCIENCES LIMITED Corporate Office Address : Block No. 284, Village : Dabhasa, Taluka : Padra, Dist.: Vadodara, Gujarat State - 391 440. Registered Office Address : Block No. 353, Village : Ekalbara, Taluka : Padra, Dist. : Vadodara, Gujarat State - 391 440. Phone No. : +91 02662 299002 CIN : L24117GJ2008PLC055460 Email : info@kronoxlabsciences.com, Webside : www.kronoxlabsciences.com KRONOX LAB SCIENCES LIMITED CIN: L24117GJ2008PLCO55460 I(I ?@ N OX Statement of Assets and Liabilities as on September 30, 2026 (Rs in lakhs) Asat Asat Particulars 30.09.2026 31.03.2026 (Unaudited) (Audited) Assets I. Non-Current Assets (a) Property, Plant and Equipment 2,868.03 2,873.34 (b) Capital Work-in-Progress 180.80 87.56 (c) Financial Assets (i) Investments. 250 2.50 (ii) Other Financial Asset 10.32 1,864.25 (d) Deferred Tax Asset (net) 48.04 40.24 3,109.69 4,867.89 Il Current Assets (a) Inventories 740.13 836.95 (b) Financial assets (i) Trade Receivables 1,882.13 2,118.52 (ii) Cash and Cash Equivalent 944.49 274.62 (iii) Bank balances other than (i) above 7,007.56 4,599.47 (c) Other Current Assets 125.55 54.81 10,699.86 7,884.37 Total Assets 13,809.55 12,752.26 Equity and liabilities Equity (a) Equity Share Capital 3,710.40 3,710.40 (b) Other Equity 9,088.24 7,902.29 Total Equity 12,798.64 11,612.69 Liabilities I. Non-Current Liabilities (a) Financial Liabilities (i) Borrowings - 100.42 (b) Provisions 15.46 237 15.46 102.79 Il Current Liabilities (a) Financial liabilities (i) Borrowings = 60.27 (ii) Trade Payables Total outstanding dues of Micro Enterprise and Small Enterprise 295.55 189.64 Total oLlltslandlng dues of Creditors other than Micro Enterprise and Small 537.68 468.48 Enterprise (iii} Other Financial Liabilities 0.54 0.16 (b) Other Current Liabilities 40.54 123.97 (c) Provisions 44.58 53.22 (d) Current Tax Liabilities (Net) 76.56 141.04 995.45 1,036.78 Total Equity and Liabilities 13,809.5 [Showing first 8,000 characters — download PDF for full document]